Loading company…
Vactech develops and licenses vaccine and diagnostic technologies.
Founded in 2001 by Heikki Hyöty and Mikael Knip, Vactech develops and licenses vaccines and diagnostic technologies. Its work includes an enterovirus-based preventive Type 1 Diabetes vaccine and virus-like particle technology. The company is based in Tampere, Finland, and raised venture funding in 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in